DUBLIN–(BUSINESS WIRE)–The “Neuromyelitis Optica Spectrum Disorder (NMOSD) – Market Insights, Epidemiology and Market Forecast-2027” drug pipelines has been added to ResearchAndMarkets.com’s offering. Neuromyelitis Optica Spectrum Disorder (NMOSD) – …
Author: Business Wire
Prospective Study for NaturalVue® Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Children
SAN ANTONIO–(BUSINESS WIRE)–Thomas Aller, OD, a global expert in the field of myopia, presented updated findings from a prospective clinical trial of NaturalVue® at AAO.
Aurinia to Participate in November Investor Conferences
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced its Chairman and CEO, Richard Glickman, will participate in two upcoming investor conferences. Wednesday, November 14, 2018, Aurinia will …
Omeros Announces Pricing of $210 Million Offering of Convertible Senior Notes Due 2023
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) (“Omeros”) today announced the pricing of an offering of $210 million aggregate principal amount of its 6.25% Convertible Senior Notes due 2023 (the “Notes”) in a private offering (the “Offeri…
New Solution for Distance and Astigmatism Vision Correction with the Visian Toric ICL
ARLINGTON, Texas–(BUSINESS WIRE)–KE Eye Centers of Texas to provide a new solution for patients with moderate to high levels of myopia and astigmatism in one simple procedure.
Omeros Corporation Reports Third Quarter 2018 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2018, which include: 3Q 2018 total and OMIDRIA® revenues were $4.6 mil…
Mutual of Omaha Launches New Vision Insurance and Enhanced Dental Product
OMAHA, Neb.–(BUSINESS WIRE)–Mutual of Omaha has launched a new vision insurance product and enhanced its existing dental insurance for employee benefits market.
The Global Ophthalmic Drugs Market is Expected to Witness a CAGR of 6.3% During 2018-2024 – The Loss of Patent is the Most Important Aspect Imposing Major Threats to Market Leaders – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The Global Ophthalmic Drugs Market” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic drugs market is expected to witness a CAGR of 6.3% during the forecast period to reach revenue of $30,13…
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Deliver…
Aerpio Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that Chief Executive Officer, …
BioTime Reports Third Quarter 2018 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–$BTX–BioTime, Inc. (NYSE American:BTX), a clinical-stage biotechnology company focused on degenerative diseases, reported financial and operating results for the third quarter ended September 30, 2018. BioTime managem…
Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Children
ATLANTA–(BUSINESS WIRE)–Thomas Aller, OD, FBCLA, an internationally recognized expert in nearsightedness in children, has presented updated findings from a prospective clinical trial of NaturalVue® (etafilcon A) 1 Day Multifocal Contact Lenses from V…
Glaukos Corporation Announces Third Quarter 2018 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Glaukos Corporation Announces Third Quarter 2018 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Techn…
Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Techn…
Ocular Therapeutix™ Reports Third Quarter 2018 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financ…
Ocular Therapeutix™ Reports Third Quarter 2018 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced financ…
Efectos en 3D regulables en cirugía endoscópica
TAICHUNG, Taiwán–(BUSINESS WIRE)–Existe la creencia generalizada de que la visualización en 3D ofrece una imagen mejorada a la cirugía mínimamente invasiva con percepción de profundidad. MedicalTek considera que una solución todavía mejor es la image…
Regelbarer 3D-Effekt in der endoskopischen Chirurgie
TAICHUNG, Taiwan–(BUSINESS WIRE)–Allgemein gilt, dass 3D-Visualisierung zu besserer Bildgebung bei minimal invasiven Operationen mit Tiefenwahrnehmung führt. MedicalTek ist überzeugt, dass 3D-Bildgebung mit regelbarer Disparität eine noch bessere Lös…